DANIEL CABANERO: Open Payments
NPI 1801525472 · LAGUNA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,387 in 51 payments from 20 companies in 2025. Trend: 2023 $459 · 2024 $1,048 · 2025 $1,387
Food & beverage: $1,309Education: $78
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $356 |
| Teleflex LLC | 6 | $132 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $128 |
| ACCORD HEALTHCARE, INC. | 5 | $113 |
| Astellas Pharma Global Development | 2 | $95 |
| Dendreon Pharmaceuticals LLC | 2 | $65 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Astellas Pharma US Inc | 2 | $55 |
| Medtronic, Inc. | 1 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
Products named: ERLEADA, Xtandi, RYBREVANT, Nubeqa, Camcevi, BARRIGEL, PROVENGE, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
